Consolidated Financial Results
for the 2nd Quarter of the Fiscal Year Ending March 31, 2020

from the beginning

Consolidated Financial Results for the 2nd Quarter Fiscal 2020 and Full-Year Forecasts

Disclaimer

Highlights

01 Consolidated Financial Results and Business Overview for the 2Q of Fiscal 2020 (FY Ending March 31, 2020)

2Q of Fiscal 2020 (1) Consolidated Financial Results

2Q of Fiscal 2020 (2) Results by Business Segment

2Q of Fiscal 2020 (3) Endoscopic Solutions Division

2Q of Fiscal 2020 (4) Therapeutic Solutions Division

2Q of Fiscal 2020 (5) Scientific Solutions Division

2Q of Fiscal 2020 (6) Imaging Division

Statement of Financial Position

Consolidated Cash Flows

02 Forecasts for Fiscal 2020

Fiscal 2020 Consolidated Forecasts

Fiscal 2020 Forecasts by Business Segment

*

03 Appendix

Supplementary Materials: 2Q of Fiscal 2020 Factors That Affected Consolidated Operating Profit

Supplementary Materials: 2Q of Fiscal 2020 Medical Business

Supplementary Materials: Expenditures etc.

Q&A

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6